Physician profile
Scott H Goodman
NPI 1265434443
$377,368.39
in general payments reported to CMS, 2019-2025
85 companies · $48K in 2025
The $48K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $64K · 2021: $122K · 2022: $29K · 2023: $23K · 2024: $22K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Honoraria: $31K · Food and Beverage: $15K · Travel and Lodging: $5,075 · Education: $23.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,212.50 |
| Honoraria | $30,937.50 |
| Food and Beverage | $15,034.25 |
| Travel and Lodging | $5,074.52 |
| Education | $23.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $135,047.04 | 2019-2025 | |
| Allergan, INC. | $81,729.00 | 2019-2022 | |
| Amgen INC. | $76,989.29 | 2019-2025 | Aimovig, Uplizna |
| Axsome Therapeutics, INC. | $35,291.74 | 2025 | Symbravo, Sunosi |
| Biohaven Pharmaceuticals, INC. | $24,967.33 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $3,678.55 | 2022 | |
| Emd Serono, INC. | $1,839.38 | 2019-2025 | Mavenclad, Mavenclad |
| Lundbeck LLC | $1,478.41 | 2019-2025 | Vyepti, Rexulti |
| Novartis Pharmaceuticals Corporation | $1,306.46 | 2019-2025 | |
| Biogen, INC. | $1,206.53 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Neurocrine Biosciences, INC. | $996.62 | 2019-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $913.50 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Ucb, INC. | $896.50 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Supernus Pharmaceuticals, INC. | $839.20 | 2019-2022 | |
| Lilly USA, LLC | $666.00 | 2019-2025 | Emgality, Amyvid, Kisunla |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $633.00 | 2019-2025 | |
| Genzyme Corporation | $588.86 | 2019-2025 | |
| Celgene Corporation | $585.06 | 2021-2025 | Zeposia |
| Csl Behring | $452.09 | 2019-2025 | Hizentra |
| Mdd US Operations, LLC | $437.21 | 2020-2025 | Gocovri, Gocovri |
| Argenx US, INC. | $422.82 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Genentech USA, INC. | $383.29 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Sunovion Pharmaceuticals INC. | $290.66 | 2020-2022 | |
| Neurelis, INC. | $285.48 | 2020-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $263.65 | 2019-2025 | Nuplazid |
| Jazz Pharmaceuticals INC. | $258.26 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $245.11 | 2019-2024 | Ultomiris |
| Ipsen Biopharmaceuticals, INC | $230.83 | 2019-2025 | Dysport |
| Adamas Pharmaceuticals, INC. | $219.68 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $196.81 | 2023-2025 | Purified Cortrophin Gel |
| Eisai INC. | $191.88 | 2019-2025 | |
| Gilead Sciences, INC. | $189.19 | 2019-2020 | |
| Livanova USA, INC. | $189.07 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Sk Life Science, INC. | $184.90 | 2020-2025 | |
| Catalyst Pharmaceuticals, INC. | $181.37 | 2024-2025 | |
| Kyowa Kirin, INC. | $179.63 | 2020-2024 | Nourianz |
| Idorsia Pharmaceuticals US INC | $140.74 | 2023 | Quviviq |
| Greenwich Biosciences, INC. | $139.89 | 2019-2021 | |
| Janssen Biotech, INC. | $134.80 | 2025 | |
| Vanda Pharmaceuticals INC. | $131.06 | 2024-2025 | Ponvory |
| Astrazeneca Pharmaceuticals Lp | $127.98 | 2023-2025 | Wainua, Brilinta |
| Grifols USA, LLC | $123.48 | 2019-2024 | Gamunex-C |
| Hospira, INC. | $123.19 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $123.16 | 2022 | |
| Amneal Pharmaceuticals LLC | $110.59 | 2020-2025 | Rytary, Crexont |
| Octapharma USA, INC. | $102.40 | 2023-2025 | Octagam Immune Globulin (Human), Panzyga |
| Boston Scientific Corporation | $94.69 | 2019-2024 | Vercise, Watchman Flx |
| Avanir Pharmaceuticals, INC. | $79.05 | 2020-2022 | |
| Acorda Therapeutics, INC | $78.17 | 2019-2021 | |
| Grt US Holding, INC. | $77.63 | 2022 | |
| Janssen Pharmaceuticals, INC | $76.44 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $74.72 | 2023 | Trudhesa |
| Mallinckrodt Hospital Products INC. | $74.21 | 2020-2024 | Acthar |
| Tanabe Pharma America, INC. | $73.71 | 2019-2023 | |
| Merz Pharmaceuticals, LLC | $71.28 | 2021-2025 | Inbrija, Xeomin |
| Medtronic USA, INC. | $71.20 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $60.28 | 2019 | |
| Tg Therapeutics, INC. | $57.73 | 2023-2025 | |
| Ge Healthcare | $57.16 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $54.87 | 2023-2025 | Rexulti, Nuedexta |
| Arbor Pharmaceuticals, INC. | $48.84 | 2021-2022 | |
| Travere Therapeutics, INC. | $46.54 | 2019-2020 | |
| Banner Life Sciences, LLC | $45.44 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $42.88 | 2023 | Aptiom |
| Upsher-Smith Laboratories LLC | $40.18 | 2022-2023 | |
| Zyla Life Sciences, INC. | $40.16 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.33 | 2020-2024 | Hyqvia |
| Horizon Therapeutics Plc | $35.55 | 2022-2023 | Uplizna |
| Avadel Cns Pharmaceuticals, LLC | $31.57 | 2024 | Lumryz |
| Tersera Therapeutics LLC | $26.51 | 2019 | |
| Xeris Pharmaceuticals, INC. | $25.50 | 2021 | |
| Tonix Medicines, INC. | $24.00 | 2025 | Zembrace Symtouch |
| Impel Pharmaceuticals LLC | $21.55 | 2025 | Trudhesa |
| Almatica Pharma LLC | $21.40 | 2021 | |
| Saol Therapeutics INC. | $21.11 | 2020 | |
| Portola Pharmaceuticals, LLC | $20.82 | 2019 | |
| Harmony Biosciences LLC | $20.28 | 2023 | Wakix |
| Promius Pharma LLC | $17.99 | 2019 | |
| Merz North America, INC. | $16.65 | 2019 | |
| Avion Pharmaceuticals | $15.80 | 2022 | |
| Philips North America LLC | $15.18 | 2023 | |
| Merck Sharp & Dohme LLC | $14.34 | 2023 | Belsomra |
| Bio Products Laboratory USA, INC. | $13.08 | 2023 | Coagadex, Gammaplex |
| Shire North American Group INC | $11.54 | 2019 | |
| Cycle Pharmaceuticals INC | $2.32 | 2024 | Tascenso Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.